Good2Go
Fran Heller is an accomplished entrepreneur and board member with extensive experience in various sectors, including healthcare and technology. As the Founder, CEO, and Board Chair of Good2Go, Inc., Fran leads the development of innovative contactless and virtual queuing solutions, delivering cost-effective SaaS products that address significant challenges for retailers. In addition to current roles on the boards of Big Sur Health Center, Lava Mae, and 1cBio, Inc. / Rareus, Fran has served on the Board of Directors for Monterey Bio Acquisition Corporation and Affinivax, which was acquired by GSK in 2022. Fran's leadership experience also includes advising pH Pharma Co., Ltd. and participating as a Trustee at Dana-Farber Cancer Institute and a board member at Tulane University's School of Science and Engineering.